Encora Therapeutics
PrivateLast Round
Seed
Sep 30, 2020
Total Funding Raised
$1.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Encora Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in September 2020.
Encora Therapeutics is a medical device company that develops non-invasive, wearable neuromodulation technology to provide on-demand relief for hand tremors in patients with conditions such as Essential Tremor and Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Encora Therapeutics Comparables
Compare Encora Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allevion Therapeutics | 89% | |
| Fasikl, Inc. | 86% | |
| Cala Health | 84% |
For institutional investors. Book with your work email.
Encora Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Encora Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Good Growth Capital | Seed |
| Engine Ventures | Seed |
| InnoSpark Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 149% MoM, reaching 5.4K.
- Jul 15, 2026
Grew 18% QoQ, from 17 to 20 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 15, 2026
Encora, Inc. makes Encora X1(TM), a non-drug, non-invasive wearable for managing hand tremor, available for order through the U.S. Department of Veterans Affairs in the United States on Oct 15th '26.
For institutional investors. Book with your work email.
Encora Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Encora Therapeutics's valuation, stock price, and market status.
Is Encora Therapeutics a public or private company?
Encora Therapeutics is a private company.
What is the current stock price of Encora Therapeutics?
Encora Therapeutics is a private company, so its shares have no public market price. Caplight tracks Encora Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Encora Therapeutics worth (valuation)?
Valuation information for Encora Therapeutics is not publicly available.
Can I buy Encora Therapeutics stock?
Encora Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Encora Therapeutics's last funding round?
Encora Therapeutics's most recent funding round was Seed on September 30, 2020.
Who are the main investors in Encora Therapeutics?
Key investors in Encora Therapeutics include InnoSpark Ventures.
Will Encora Therapeutics IPO soon?
No public IPO plans have been announced for Encora Therapeutics.
How can I track Encora Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Encora Therapeutics's shares on secondary markets.